Immunothérapie allergénique dans le traitement de l’allergie aux pollens
Authors:
- 1 February 2013
- journal article
- abstracts
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 30 (2) , 142-151
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen–induced rhinoconjunctivitisJournal of Allergy and Clinical Immunology, 2011
- Immunotherapy with peptidesAllergy, 2011
- Recombinant allergens for allergen-specific immunotherapy: 10 years anniversary of immunotherapy with recombinant allergensAllergy, 2011
- Role of immunmodulators in allergen-specific immunotherapyAllergy, 2011
- Immunological mechanisms of sublingual allergen-specific immunotherapyAllergy, 2011
- The efficacy of sublingual immunotherapy for house dust mites respiratory allergy: results of a GA²LEN meta‐analysisAllergy, 2009
- Intralymphatic allergen administration renders specific immunotherapy faster and safer: A randomized controlled trialProceedings of the National Academy of Sciences, 2008
- Comparison of the efficacy of subcutaneous and sublingual immunotherapy in mite-sensitive patients with rhinitis and asthma—a placebo controlled studyAnnals of Allergy, Asthma & Immunology, 1999
- Sublingual versus injective immunotherapy in grass pollen allergic patients: a double blind (double dummy) studyClinical & Experimental Allergy, 1996
- Systemic reactions to specific immunotherapy in children with respiratory allergy: a prospective studyPediatric Allergy and Immunology, 1995